Activation of M<sub>1</sub> and M<sub>4</sub> muscarinic receptors as potential treatments for Alzheimer&#39;s disease and schizophrenia

Daniel J Foster; Derrick L Choi; P Jeffrey Conn; Jerri M Rook

doi:10.2147/NDT.S55104

open access to scientific and medical research

Back to Journals » Neuropsychiatric Disease and Treatment » Volume 10

Review

Activation of M₁ and M₄ muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia

Total article views		HTML views	PDF downloads	Totals
26,859	Dovepress*	17,658+	2,495	20,153
	PubMed Central*	9,201	1,558	10,759
	Totals	26,859	4,053	30,912
*Since 28 January 2014 +Since July 2016

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
10	0	0	0	4	6

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.

Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia

Activation of M₁ and M₄ muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia